Coleman Blaise

Avg. Two Year Performance

(72%) Avg. Purchase Return
(31%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return9%(15%)(21%)103%(72%)
Purchase Success Rate1 of 10 of 10 of 11 of 10 of 1
Average Sale Return----------
Sale Success Rate----------
Drugs » Drug Manufacturers - Other

President, CEO, Director:

Holdings: 1.76M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--